You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
安圖生物(603658.SH):藥品生產許可證到期失效
格隆匯 12-28 16:59

格隆匯12月28日丨安圖生物(603658.SH)公佈,公司持有的《藥品生產許可證》將於2020年12月31日到期失效。

公司持有的《藥品生產許可證》(許可證編號:豫20160295)有效期至2020年12月31日;生產範圍為:體外診斷試劑(乙型肝炎病毒表面抗原診斷試劑盒(酶聯免疫法)、丙型肝炎病毒抗體診斷試劑盒(酶聯免疫法)、人類免疫缺陷病毒抗體診斷試劑盒(酶聯免疫法))。公司根據現有產品線佈局進行資源整合,已經停止上述產品的生產,並向河南省藥品監督管理局遞交“《藥品生產許可證》註銷申請”。

截至2020年9月30日,公司以上三項藥品的最近三年一期的銷售佔比分別為0.5%、0.52%、0.28%及0.02%,呈逐年下降趨勢,對公司經營業績影響較小。公司本次《藥品生產許可證》到期失效對後續生產經營無明顯影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account